Senior insider sale
CMO, SVP & Head of Drug Devt. at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$377.4K
83.31K shares
SHETZLINE MICHAEL plans to sell 83.31K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $377.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/10/2026 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan N/A | 34.15K | — |
3/10/2026 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan N/A | 31.24K | — |
2/10/2025 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan N/A | 33.33K | — |
2/10/2025 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan N/A | 30.49K | — |
2/12/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan N/A | 13.61K | — |
2/12/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan N/A | 12.45K | — |
3/8/2023 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan N/A | 17.47K | — |
| Total | 172.74K | ||
Units to sell
83.31K
Market value
$377.4K
Units
83.31K
Value
$377.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/24/2026 | 83.31K | $377.4K | Nasdaq | Planned |
| Total | 83.31K | $377.4K | ||